KROS (STOCKS)
Keros Therapeutics, Inc. Common Stock
$16.610000
-0.430000 (-2.52%)
Prev close: $17.040000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jasbir S. Seehra
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $506.04M
- Employees
- 82
- P/E (TTM)
- 11.04
- P/B (TTM)
- 0.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.18 | $-1.07 | +0.8879 | +83.14% |
|
Jun 2025 (Q2)
|
$-0.76 | $-1.15 | +0.3945 | +34.17% |
|
Mar 2025 (Q1)
|
$3.62 | $-0.25 | +3.8679 | +1,560.27% |
|
Dec 2024 (Q4)
|
$-1.14 | $-1.00 | -0.1373 | -13.69% |
Financial Statements
| Revenues | $246.53M |
| Benefits Costs and Expenses | $175.38M |
| Costs And Expenses | $159.13M |
| Nonoperating Income/Loss | $27.56M |
| Operating Expenses | $203.13M |
| Research and Development | $157.36M |
| Other Operating Expenses | $45.77M |
| Operating Income/Loss | $43.59M |
| Income/Loss From Continuing Operations After Tax | $64.45M |
| Income/Loss From Continuing Operations Before Tax | $71.15M |
| Income Tax Expense/Benefit | $6.70M |
| Net Income/Loss | $64.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $64.45M |
| Net Income/Loss Available To Common Stockholders, Basic | $64.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.60 |
| Diluted Earnings Per Share | $1.56 |
| Basic Average Shares | 41,572,523 |
| Diluted Average Shares | 42,176,117 |
| Assets | $742.78M |
| Current Assets | $719.31M |
| Noncurrent Assets | $23.48M |
| Fixed Assets | $4.56M |
| Other Non-current Assets | $18.91M |
| Liabilities | $39.20M |
| Current Liabilities | $24.09M |
| Accounts Payable | $2.30M |
| Wages | $8.95M |
| Other Current Liabilities | $12.84M |
| Noncurrent Liabilities | $15.11M |
| Equity | $703.58M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $703.58M |
| Liabilities And Equity | $742.78M |
| Net Cash Flow From Operating Activities | $88.79M |
| Net Cash Flow From Operating Activities, Continuing | $88.79M |
| Net Cash Flow From Investing Activities | -$1.71M |
| Net Cash Flow From Investing Activities, Continuing | -$1.71M |
| Net Cash Flow From Financing Activities | $75.71M |
| Net Cash Flow From Financing Activities, Continuing | $75.71M |
| Net Cash Flow | $162.79M |
| Net Cash Flow, Continuing | $162.79M |
| Comprehensive Income/Loss | $64.45M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $64.45M |
| Other Comprehensive Income/Loss | $0.00 |